CN107308404A - A kind of lipid-loweringing moxa-moxibustion formula - Google Patents
A kind of lipid-loweringing moxa-moxibustion formula Download PDFInfo
- Publication number
- CN107308404A CN107308404A CN201710436966.3A CN201710436966A CN107308404A CN 107308404 A CN107308404 A CN 107308404A CN 201710436966 A CN201710436966 A CN 201710436966A CN 107308404 A CN107308404 A CN 107308404A
- Authority
- CN
- China
- Prior art keywords
- moxibustion
- moxa
- lipid
- loweringing
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 claims abstract description 30
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 17
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 17
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 17
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 17
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 17
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 17
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 17
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 17
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 17
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 17
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 17
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 17
- 240000004980 Rheum officinale Species 0.000 claims abstract description 17
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 17
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 17
- 125000003118 aryl group Chemical group 0.000 claims abstract description 17
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 17
- 235000005412 red sage Nutrition 0.000 claims abstract description 17
- 235000013976 turmeric Nutrition 0.000 claims abstract description 17
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 3
- 240000001398 Typha domingensis Species 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims description 28
- 239000011159 matrix material Substances 0.000 claims description 17
- 238000001467 acupuncture Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 6
- 239000002674 ointment Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 235000010894 Artemisia argyi Nutrition 0.000 claims 1
- 244000030166 artemisia Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 5
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 2
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 2
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 2
- 239000008280 blood Substances 0.000 description 24
- 210000004369 blood Anatomy 0.000 description 24
- 241000233948 Typha Species 0.000 description 15
- 241001092040 Crataegus Species 0.000 description 14
- 208000002193 Pain Diseases 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 8
- 229940079593 drug Drugs 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 201000005577 familial hyperlipidemia Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048214 Xanthoma Diseases 0.000 description 1
- 206010048215 Xanthomatosis Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000003694 hair properties Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/06—Devices for heating or cooling such points within cell-life limits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
- A61H2201/0207—Characteristics of apparatus not provided for in the preceding codes heated or cooled heated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2205/00—Devices for specific parts of the body
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Rehabilitation Therapy (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a kind of lipid-loweringing moxa-moxibustion formula, component includes：By percentage to the quality, folium artemisiae argyi 40~80%, hawthorn 2~10%, rheum officinale 2~10%, rhizoma alismatis 2~10%, the red sage root 2~10%, cattail pollen 2~10%, root tuber of aromatic turmeric 2~10%.The formula is prepared as Moxibustion strip and moxa-moxibustion cream individually or used cooperatively, and formula is unique, instant effect, good effect, and using safety, with excellent fat-reducing effect, played a role when other diseases have not yet been formed in Hyperlipidemia, reach and prevent trouble before it happens, the purpose for preventing cardiovascular and cerebrovascular disease from occurring.
Description
Technical field
The present invention relates to moxa-moxibustion technical field, more particularly to a kind of lipid-loweringing moxa-moxibustion formula, lipid-loweringing moxa-moxibustion formula is prepared into
Moxibustion bar and moxibustion cream there is good lipid-lowering effect.
Background technology
Hyperlipemia refers to that blood lipid level is too high, the disease that can directly cause some to seriously endanger health, is a kind of
Common disease.Hyperlipemia is also to promote hypertension, IGT, an important risk factor of diabetes, be can also result in
Fatty liver, hepatic sclerosis, cholelithiasis, pancreatitis, fundus hemorrhage, blindness, peripheral vascular disease, limping, hyperuricemia.Some are former
Hair property and familial hyperlipemia it may also occur that tendon shape, nodositas, the palm plane and eye socket around xanthoma, embryotoxon
Deng.High fat of blood incidence of disease among the elderly is high, and it causes atherosclerosis, or even coronary heart disease, cerebral thrombus, cerebral hemorrhage
Deng threat to life.Therefore, hyperlipidemia is not only blood fat height a bit, and its seriousness can not definitely be ignored.
Moxa-moxibustion results from ancient dynasties of China, be Ai heat that the moxa-moxibustion material that is made of folium artemisiae argyi is produced stimulate body surface point or
Privileged site, the biochemical functions of human disorder are adjusted by the activity of stimulating Qi of meridian, so as to reach the mesh prevented and cured diseases
's.
Treatment method currently for high fat of blood is mainly treated by Oral Chemical fat-reducing medicament, but long-term mouth
The chemical fat-reducing medicament increase liver kidney metabolic burden of clothes, with certain drug side-effect, many patients are difficult to adhere to, it is difficult to meet
Patient needs.High fat of blood is treated by way of moxa-moxibustion has far-reaching Research Significance.
The content of the invention
In view of this, the invention provides a kind of lipid-loweringing moxa-moxibustion formula, the moxa-moxibustion, which is matched somebody with somebody, can be prepared as Moxibustion strip or moxa-moxibustion
Used after cream, act on particular acupoint, with good fat-reducing effect.
The invention provides a kind of lipid-loweringing Moxibustion strip formula, component by percentage to the quality, folium artemisiae argyi 40~80%, hawthorn 2
~8%, rheum officinale 2~8%, rhizoma alismatis 2~8%, the red sage root 2~8%, cattail pollen 2~8%, root tuber of aromatic turmeric 2~8%.
A kind of lipid-loweringing moxa-moxibustion paste formulation, component by percentage to the quality, Chinese medicine patch matrix 40~60%, hawthorn 2~
10%, rheum officinale 2~10%, rhizoma alismatis 2~10%, the red sage root 2~10%, cattail pollen 2~10%, root tuber of aromatic turmeric 2~10%.
Further, the invention provides a kind of lipid-loweringing moxibustion method, step includes：It is formulated and is made using above-mentioned lipid-loweringing moxa-moxibustion
Moxibustion strip, moxa-moxibustion cream moxa-moxibustion is carried out to acupuncture point, per cave 30~50 minutes once a day, the next day 1 time, 12 times are a course for the treatment of,
2 courses for the treatment of of common moxibustion.
The beneficial effects of the invention are as follows：The present invention is harmless using traditional Chinese medicine ingredients, and formula is unique, with good
Effect for reducing fat, plays a role when other diseases have not yet been formed in Hyperlipidemia, reaches and prevents trouble before it happens, and prevents heart and brain blood
The purpose that pipe disease occurs.Moxibustion cream or moxibustion bar can be prepared as needed, are used alone or are used cooperatively, with the use of effect more
Good, safely and effectively, suitable various people use, and Clinical practice effect is obvious.
Embodiment
The invention provides a kind of lipid-loweringing moxa-moxibustion formula.Lipid-loweringing Moxibustion strip be formulated, component by percentage to the quality, folium artemisiae argyi 40
~80%, hawthorn 2~8%, rheum officinale 2~8%, rhizoma alismatis 2~8%, the red sage root 2~8%, cattail pollen 2~8%, root tuber of aromatic turmeric 2~8%.Lipid-loweringing
Moxa-moxibustion paste formulation, by percentage to the quality, Chinese medicine patch matrix 40~60%, hawthorn 2~10%, rheum officinale 2~10% is damp for component
Rush down 2~10%, the red sage root 2~10%, cattail pollen 2~10%, root tuber of aromatic turmeric 2~10%.Based on folium artemisiae argyi, warming YANG and invigorating QI, warming and activating meridian,
Dispersing blood stasis dissipating bind, tonifying middle-Jiao and Qi, coordinate hawthorn, rheum officinale, rhizoma alismatis, the red sage root, cattail pollen, root tuber of aromatic turmeric, and lipid-loweringing disappears fat, promote the metabolism of fat with turning
Change, mutually promoted between each composition, lipid-lowering effect is obvious.
The pharmacological effect of each raw material is as follows：
Folium artemisiae argyi：Nature and flavor acrid, bitter, warm, slightly poisonous, Return liver, spleen, kidney channel.With warming channel for arresting bleeding, eliminating cold to stop pain effect, external application
Removing dampness to stop itchin.For spitting blood, blood nosebleed, uterine bleeding, menorrhalgia, blood, few abdomen crymodynia under threatened abortion, through uncomfortable, uterus cold infertile of trembling with fear, control outside
Pruitus.
Hawthorn：Aid digestion, reducing blood lipid, antiatherosclerosis are usually used in indigestion, coronary heart diseases and angina pectoris, hyperlipemia
Disease etc..
Rheum officinale：Expel the heat-evil logical intestines, removing pattogenic heat from the blood and toxic material from the body, dispelling stasis of blood and stimulating the menstrual flow.For real heat constipation, product lets out stomachache, and rush down dysentery is not well, damp and hot Huang
Subcutaneous ulcer, hot eyes, pharynx swelling, abdominalgia with intestinal abscess, carbuncle swells furunculosis, blood stasis closed, injury from falling down.
Rhizoma alismatis：Nature and flavor are sweet, light cold, return kidney, bladder warp.With clearing damp and promoting diuresis, expel the heat-evil, change turbid fat-reducing effect.For urine
Unfavorable, oedema turgor, oliguria of having loose bowels, phlegmatic vertigo, puckery pain of heat gonorrhea, hyperlipidemia.
The red sage root：Stasis-dispelling and pain-killing, invigorate blood circulation, relieving restlessness that clears away heart-fire.For irregular menstruation, Amenorrhea is stimulated the menstrual flow, chest and abdomen shouting pain, hot numbness pain
Bitterly, sore swell and ache curative, dysphoria and insomnia；Hepatosplenomegaly, angina pectoris.
Cattail pollen：Cattail pollen nature and flavor are sweet, flat, Return liver, pericardium channel.With hemostasis, stagnation resolvation, treating stranguria effect, for spitting blood, bleeding from five sense organs or subcutaneous tissue,
Spitting of blood, uterine bleeding, traumatism and bleeding, amenorrhoea dysmenorrhoea, chest and abdomen shouting pain, tumbling and swelling, blood strangury and dry pain.
Root tuber of aromatic turmeric：Regulating qi to disperse stagnation, heart fire-clearing upset-relieving, normalizing gallbladder to cure jaundice.Stimulated the menstrual flow for Amenorrhea, chest and abdomen swelling and pain, shouting pain, pyreticosis coma,
Epilepsy is gone mad, jaundice.
It is preferred that, component includes：By percentage to the quality, folium artemisiae argyi 60~80%, hawthorn 2~8%, rheum officinale 2~8%, pool
Rush down 2~8%, the red sage root 2~8%, cattail pollen 2~8%, root tuber of aromatic turmeric 2~8%.
More preferred, the lipid-loweringing moxa-moxibustion formula is prepared as using after Moxibustion strip, and the Moxibustion strip preparation process includes：
Each component is respectively crushed into powder, folium artemisiae argyi presses 5~8:1 moxa processed, each component is mixed in proportion, rolls tightly into bar, and bonding is closed,
Dried 2 hours at a temperature of being placed on 50 DEG C.
It is preferred that, component includes：By percentage to the quality, matrix 40~60%, hawthorn 2~10%, rheum officinale 2~10%,
Rhizoma alismatis 2~10%, the red sage root 2~10%, cattail pollen 2~10%, root tuber of aromatic turmeric 2~10%.
More preferred, the lipid-loweringing moxa-moxibustion formula is used after being prepared as moxa-moxibustion cream, the moxa-moxibustion ointment preparation step
Including：Each component was crushed to 100 sieves respectively, Traditional Chinese medicine ointment patch is added in matrix as matrix after other components are well mixed,
Stir.
A kind of lipid-loweringing moxibustion method, step includes：Using above-mentioned moxibustion patch acupuncture point, per cave once a day, 2~4 is small every time
When；Or by above-mentioned moxibustion patch acupuncture point, while carrying out moxa-moxibustion to acupuncture point across moxibustion cream using above-mentioned moxibustion bar, per cave once a day, often
Secondary 30~50 minutes, the next day 1 time.12 times are a course for the treatment of, altogether 2 courses for the treatment of of moxibustion.
It is further described below in conjunction with the lipid-loweringing moxa-moxibustion formula that specific embodiment is provided the present invention.Describe below
Embodiment be exemplary, be only used for explaining the present invention, and be not considered as limiting the invention.
Experimental method in following embodiments, is conventional method unless otherwise specified.Reality used in following embodiments
Test material unless otherwise specified, be that market is commercially available.
Embodiment 1
Present embodiments provide a kind of lipid-loweringing Moxibustion strip and a kind of lipid-loweringing moxa-moxibustion cream.
A kind of lipid-loweringing Moxibustion strip, component includes, by percentage to the quality, folium artemisiae argyi 70%, hawthorn 5%, rheum officinale 5%, rhizoma alismatis
5%, the red sage root 5%, cattail pollen 5%, root tuber of aromatic turmeric 5%.
The Moxibustion strip is prepared as follows：Step includes：Each component is respectively crushed into powder, folium artemisiae argyi presses 5:1
Moxa processed, each component is mixed in proportion, rolls tightly into bar, and bonding closing is dried 2 hours at a temperature of being placed on 50 DEG C.
A kind of lipid-loweringing moxa-moxibustion cream, component includes：By percentage to the quality, matrix 40%, hawthorn 10%, rheum officinale 10%, pool
Rush down 10%, the red sage root 10%, cattail pollen 10%, root tuber of aromatic turmeric 10%.
The moxa-moxibustion cream is prepared as follows：Step includes：Each component was crushed to 100 sieves, the base respectively
Matter is the carrier of each medicine, using conventional Traditional Chinese medicine ointment patch matrix, adds in matrix, stirs after other components are well mixed
Mix uniform.
Moxa-moxibustion is carried out to particular acupoint using above-mentioned medicine Moxibustion strip, medicine moxa-moxibustion cream, acupuncture point takes 1. huge valve, Tianshu (double), rich
Grand (double)；2. Hsinshu (acupoint) (double), bl (double), Pishu (double).Medication moxa-moxibustion patch acupuncture point, every cave 2--4 hours once a day, or
Medication Moxibustion strip was every medicine moxa-moxibustion cream moxibustion, per cave 30--50 minutes once a day, the next day 1 time.3 times a week, 12 times are a course for the treatment of, altogether
2 courses for the treatment of of moxibustion.
It will be applied to Moxibustion strip of adding medicine to, medicine moxa-moxibustion cream in clinical practice to observe drug effect, and pass through the diagnosis and treatment and sight of patient
Examine, it is for treating hyperlipemic patients lipid-loweringing total effective rate up to more than 99%.
Case 100 is selected altogether, wherein 43 in hospital, it is non-to be in hospital 57.In selected case, male 68, women 32
Example, minimum 35 years old of age, maximum 67 years old, average age 51 years old.
Treatment method：For carrying out reducing blood lipid treatment but not occurring the patient of complication, using moxa-moxibustion cream and moxa-moxibustion
Bar is with the use of the therapeutic lipid-loweringing of progress；The patient for not carrying out for the slightly biased height of blood fat but reducing blood lipid treatment, is entered using Moxibustion strip
Row health lipid-loweringing.Each patient's 2 courses for the treatment of of equal moxibustion.
Curative effect is observed：Blood drawing measurement blood fat.
Curative effect judging standard：
It is effective：Lipids detection reaches following wantonly 1 person：TC decline >=20%, TG >=40%, HCL-G of decline risings >=
0.26mmoI/L(10mg/dI)；
Effectively：Lipids detection reaches following wantonly 1 person：TC declines >=5% but ＜ 20%, and TG declines >=10% but ＜ 40%,
HCL-G risings >=0.104mmoI/L (4mg/dI) but ＜ 0.26mmoI/L (10mg/dI)；
It is invalid：The lipid determination person of being not improved.
Clinical test results：After 2 course of therapy, the case 94 of effective standard is reached, is left case blood fat and surveys
Though effective standard is not up to surely but improvement trend is also presented compared to lipids detection result before treatment.
The result of clinical practice shows that the Moxibustion strip and moxa-moxibustion cream that the present embodiment is provided have good effect for reducing fat, can
Played a role when other diseases have not yet been formed in Hyperlipidemia, reach and prevent trouble before it happens, prevent cardiovascular and cerebrovascular disease
Occur, be finally reached the effect cured the disease.For the slightly higher crowd of blood fat, effective health care fat-reducing effect may also function as.
Embodiment 2
Present embodiments provide a kind of lipid-loweringing Moxibustion strip and a kind of lipid-loweringing moxa-moxibustion cream.
A kind of lipid-loweringing Moxibustion strip, component includes, by percentage to the quality, folium artemisiae argyi 60%, hawthorn 8%, rheum officinale 8%, rhizoma alismatis
8%, the red sage root 7%, cattail pollen 7%, root tuber of aromatic turmeric 2%.
The Moxibustion strip is prepared as follows：Each component is first respectively crushed into powder, folium artemisiae argyi presses 8:1 moxa processed,
Each component is mixed according to the above ratio again, bar is rolled tightly into, bonding closing is dried 2 hours at a temperature of being placed on 50 DEG C.
A kind of lipid-loweringing moxa-moxibustion cream, component includes：By percentage to the quality, matrix 50%, hawthorn 8%, rheum officinale 8%, rhizoma alismatis
8%, the red sage root 8%, cattail pollen 9%, root tuber of aromatic turmeric 9%.
The moxa-moxibustion cream is prepared as follows：Step includes：Each component was crushed to 100 sieves respectively, with Chinese medicine
Cream patch substrate as matrix, then by other components it is well mixed after add in matrix, stir.
Moxa-moxibustion is carried out to particular acupoint using above-mentioned medicine Moxibustion strip, medicine moxa-moxibustion cream, acupuncture point takes 1. huge valve, Tianshu (double), rich
Grand (double)；2. Hsinshu (acupoint) (double), bl (double), Pishu (double).Medication moxa-moxibustion patch acupuncture point, every cave 2--4 hours once a day, or
Medication Moxibustion strip was every medicine moxa-moxibustion cream moxibustion, per cave 30--50 minutes once a day, the next day 1 time.3 times a week, 12 times are a course for the treatment of, altogether
2 courses for the treatment of of moxibustion.
Above lipid-loweringing Moxibustion strip and lipid-loweringing moxa-moxibustion cream are applied in clinical practice to observe fat-reducing effect, curative effect is with implementing
Example 1 is basically identical.
Embodiment 3
Present embodiments provide a kind of lipid-loweringing Moxibustion strip and a kind of lipid-loweringing moxa-moxibustion cream.
A kind of lipid-loweringing Moxibustion strip, component includes, by percentage to the quality, folium artemisiae argyi 80%, hawthorn 4%, rheum officinale 4%, rhizoma alismatis
4%, the red sage root 4%, cattail pollen 2%, root tuber of aromatic turmeric 2%.
The Moxibustion strip is prepared as follows：Each component is first respectively crushed into powder, folium artemisiae argyi presses 6:1 moxa processed,
Each component is mixed in proportion, bar is rolled tightly into, bonding closing is dried 2 hours at a temperature of being placed on 50 DEG C.
A kind of lipid-loweringing moxa-moxibustion cream, component includes：By percentage to the quality, matrix 60%, hawthorn 5%, rheum officinale 5%, rhizoma alismatis
5%, the red sage root 5%, cattail pollen 10%, root tuber of aromatic turmeric 10%.
The moxa-moxibustion cream is prepared as follows：Step includes：Each component was crushed to 100 sieves, traditional Chinese medicinal ointment respectively
Patch substrate is added in matrix after other components are well mixed, stirred as matrix.
Moxa-moxibustion is carried out to particular acupoint using above-mentioned medicine Moxibustion strip, medicine moxa-moxibustion cream, acupuncture point takes 1. huge valve, Tianshu (double), rich
Grand (double)；2. Hsinshu (acupoint) (double), bl (double), Pishu (double).Medication moxa-moxibustion patch acupuncture point, every cave 2--4 hours once a day, or
Medication Moxibustion strip was every medicine moxa-moxibustion cream moxibustion, per cave 30--50 minutes once a day, the next day 1 time.3 times a week, 12 times are a course for the treatment of, altogether
2 courses for the treatment of of moxibustion.
Above lipid-loweringing Moxibustion strip and lipid-loweringing moxa-moxibustion cream are applied in clinical practice to observe fat-reducing effect, curative effect is with implementing
Example 1 is basically identical.
The foregoing is only presently preferred embodiments of the present invention, be not intended to limit the invention, it is all the present invention spirit and
Within principle, any modification, equivalent substitution and improvements made etc. should be included in the scope of the protection.
Claims (6)
1. a kind of lipid-loweringing Moxibustion strip formula, it is characterised in that：Component by percentage to the quality, folium artemisiae argyi 40~80%, hawthorn 2~
8%, rheum officinale 2~8%, rhizoma alismatis 2~8%, the red sage root 2~8%, cattail pollen 2~8%, root tuber of aromatic turmeric 2~8%.
2. lipid-loweringing Moxibustion strip formula as claimed in claim 1, it is characterised in that：The lipid-loweringing moxa-moxibustion formula is prepared as Moxibustion strip
After use, the Moxibustion strip preparation method step includes：Each component is respectively crushed into powder, by folium artemisiae argyi：Moxa is 5~8:1
Ratio moxa, each component is mixed in proportion, rolls tightly into bar, and bonding closing is dried 2 hours at a temperature of being placed on 50 DEG C.
3. lipid-loweringing Moxibustion strip formula as claimed in claim 1 or 2, it is characterised in that：The folium artemisiae argyi uses Chinese mugwort.
4. a kind of lipid-loweringing moxa-moxibustion paste formulation, it is characterised in that：Component by percentage to the quality, Chinese medicine patch matrix 40~60%,
Hawthorn 2~10%, rheum officinale 2~10%, rhizoma alismatis 2~10%, the red sage root 2~10%, cattail pollen 2~10%, root tuber of aromatic turmeric 2~10%.
5. lipid-loweringing moxa-moxibustion paste formulation as claimed in claim 4, it is characterised in that：The lipid-loweringing moxa-moxibustion formula is prepared as moxa-moxibustion cream
After use, the moxa-moxibustion ointment preparation step includes：Each component was crushed respectively 100 sieve, Traditional Chinese medicine ointment patch as matrix,
Add in matrix, stir after other components are well mixed.
6. a kind of lipid-loweringing moxibustion method, it is characterised in that：Moxibustion strip, moxa-moxibustion cream made from being formulated as described in claim 1,4
Moxa-moxibustion is carried out to acupuncture point, per cave 30~50 minutes once a day, the next day 1 time, 12 times are a course for the treatment of, altogether 2 courses for the treatment of of moxibustion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710436966.3A CN107308404A (en) | 2017-06-12 | 2017-06-12 | A kind of lipid-loweringing moxa-moxibustion formula |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710436966.3A CN107308404A (en) | 2017-06-12 | 2017-06-12 | A kind of lipid-loweringing moxa-moxibustion formula |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107308404A true CN107308404A (en) | 2017-11-03 |
Family
ID=60181760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710436966.3A Pending CN107308404A (en) | 2017-06-12 | 2017-06-12 | A kind of lipid-loweringing moxa-moxibustion formula |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107308404A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111920928A (en) * | 2020-08-07 | 2020-11-13 | 李�浩 | Moxibustion medicinal cake and preparation method thereof |
-
2017
- 2017-06-12 CN CN201710436966.3A patent/CN107308404A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111920928A (en) * | 2020-08-07 | 2020-11-13 | 李�浩 | Moxibustion medicinal cake and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1939491A (en) | Chinese medicinal herbs for treating spur and its preparation | |
| CN104147284B (en) | Chinese herbal preparation for treating epilepsy and preparation method thereof | |
| CN104644943A (en) | Traditional Chinese medicine composition, medicinal moxibustion containing same and preparation method | |
| CN1330352C (en) | Health care wine and preparation method | |
| CN103816417A (en) | Traditional Chinese medicine composition for treating infantile convulsion and preparation method thereof | |
| CN107095905A (en) | A kind of healthful moxibustion bar and moxibustion cream | |
| CN107308404A (en) | A kind of lipid-loweringing moxa-moxibustion formula | |
| CN102716334A (en) | Chinese medicinal composition for dispelling the cold and removing stasis | |
| CN106265988A (en) | A kind of thin medicine moxibustion bar and preparation method thereof | |
| CN1824194A (en) | Pure Chinese medicine external use body fat reducing medicine | |
| CN106038698B (en) | It is a kind of for tcm product of moxibustion and preparation method thereof | |
| CN107334850A (en) | A kind of internal organs Moxibustion strip and moxa-moxibustion cream | |
| CN101637577A (en) | Traditional Chinese medicine for curing hemorrhagic strokes | |
| CN101181456B (en) | Plaster for curing bone fracture assimilation and preparation method thereof | |
| CN110327387A (en) | The Chinese medicinal plaster and preparation method thereof for treating tinnitus | |
| CN104127581A (en) | Formula and preparation method of external traditional Chinese medicine for treating burns | |
| CN115154550B (en) | A kind of external Chinese medicinal composition for treating ulcerative lymph node tuberculosis | |
| CN103830666B (en) | One treats hypertensive Chinese lavipeditum composition | |
| CN116763882B (en) | Sanjiu plaster and preparation method and application thereof | |
| CN108904705A (en) | A kind of Chinese medicine composition for treating postmenopausal women gouty arthritis,chronic | |
| CN1313137C (en) | Powder for curing pains of muscles and bones | |
| CN108159276A (en) | A kind of fumigation liquid and preparation method thereof and application method | |
| CN106729065A (en) | Fuling peel folium artemisiae argyi sweet basil moxibustion post | |
| CN105878926A (en) | External traditional Chinese medicament for treating plane warts | |
| CN105796992A (en) | Oral liquid for effective treatment of oral ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171103 |